Archives

by in
Entry Author Date Location
Now Biotech-Only, Atlas Reloads With $280M Fund For New Startups 04/17/15 Boston
Pop That Bubble: 5 Reasons Biotech Needs A Different Metaphor 04/14/15 National
Hunting for an IPO? Voyager Gets $60M From “Crossover” Backers 04/13/15 Boston
Doudna’s Caribou Bio Raises $11M To Expand Uses For Gene Editing Tech 04/02/15 San Francisco
Flagship Ventures Raises Sails for $537M Fund, Its Largest to Date 03/26/15 Boston
Alexion Deal in Hand, Blueprint Readies IPO Pitch 03/23/15 Boston
Ex-Alnylam Exec to Steer Warp Drive Bio; Verdine Shifts Roles 03/04/15 Boston
Blueprint Cuts $265M Alexion Deal With IPO in Sight 03/03/15 Boston
Genzyme Buys into Neuro Gene Therapies With $845M Voyager Pact 02/11/15 Boston
East Coast Biotech Roundup: Hamburg, Merck, Annovation, WaVe & More 02/09/15 Boston
West Coast Biotech Roundup: Tracon, Mirati, Third Rock, & Dendreon 02/06/15 San Diego
J.P. Morgan 2015: Notes, Thoughts, And Conversations From the Vortex 01/16/15 National
Genentech Redux? Roche Buys Majority Stake in Foundation Medicine 01/12/15 Boston
“Innovation at Biotech’s Epicenter,” Dec. 17: Check Out the Agenda 12/10/14 San Francisco
East Coast Biotech Roundup: Unum, RaNA, Maxwell, Biogen, & More 12/05/14 Boston
New Research Could (Finally) Remove RNAi’s Commercial Limitations 11/17/14 National
East Coast Biotech Roundup: Regeneron, Sage, Tara, Alnylam, & More 11/14/14 Boston
Sage’s Drug For Rare Epilepsy Shows Promise in Small Study 11/10/14 Boston
UCSF Chancellor Hawgood Kicks Off “Biotech’s Epicenter” Forum 12/17 10/28/14 San Francisco
Six Takeaways from Boston’s Life Science Disruptors 10/13/14 Boston
One Week to Boston’s Life Science Disruptors—Check Out the Agenda 10/01/14 Boston
MyoKardia, Sanofi Ink $200M+ Deal for Targeted Heart Drugs 09/17/14 San Francisco
Hear Epizyme, Sage, Zafgen Share Their Stories on Oct. 8 09/11/14 Boston
John Maraganore: From “Prototypical Geek” To Canny Alnylam Chief 09/07/14 Boston
East Coast Biotech Roundup: Infinity, Merck, Voyager, Ebola, & More 09/05/14 Boston
Steven Paul, Former Lilly R&D Chief, Takes Head Seat at Voyager 09/03/14 Boston
East Coast Biotech Roundup: Biogen, Civitas, Rhythm, Alkermes, & More 08/29/14 Boston
ARCH Venture Exploits IPO Window To Raise $400M Fund, Its Eighth 08/27/14 Seattle
Coelacanths And Other IPO Thoughts Before The Autumn Markets Return 08/26/14 National
Join Us For “Boston’s Life Science Disruptors” on Oct. 8 08/21/14 Boston
Page 1 of 13 next page »